FDA approves sotatercept for treatment of pulmonary arterial hypertension in adults Dr. Kamal Kant Kohli28 March 2024 7:30 PM ISTThe US Food and Drug Administration has approved sotatercept (Winrevair) for treatment of pulmonary arterial hypertension (PAH) in adults....
FDA okays pemivibart to prevent COVID-19 in immunocompromised patients Dr. Kamal Kant Kohli26 March 2024 8:30 AM ISTFood and Drug Administration (FDA) has granted emergency use authorization (EUA) for monoclonal antibody pemivibart to prevent COVID-19 in...
Single tablet combo of macitentan and tadalafil receives US FDA approval for pulmonary artery hypertension Dr. Kamal Kant Kohli25 March 2024 3:30 AM ISTUSA: A single-tablet combination of macitentan and tadalafil (Opsynvi) has received approval from the US Food and Drug Administration (FDA) as the...
FDA Approves novel Treatment for Duchenne Muscular Dystrophy Dr. Kamal Kant Kohli22 March 2024 3:30 PM ISTDuchenne Muscular Dystrophy is a rare neurological disorder of children which causes progressive muscle weakness due to a lack of muscle protein...
FDA Approves First Gene Therapy for rare genetic disease affecting brain and nervous system in kids Dr. Kamal Kant Kohli19 March 2024 3:00 AM ISTThe U.S. Food and Drug Administration has approved first Gene Therapy for rare genetic disease affecting brain and nervous system in kids.Lenmeldy...
First-ever nasal spray for treating chronic rhinosinusitis without nasal polyps receives US FDA approval Dr. Kamal Kant Kohli17 March 2024 9:15 PM ISTUSA: Fluticasone propionate nasal spray has received approval from the US Food and Drug Administration (FDA) as the first treatment of chronic...
FDA Approves First Treatment for Patients with Liver scarring Due to NASH Dr. Kamal Kant Kohli15 March 2024 10:30 PM ISTThe U.S. Food and Drug Administration has approved Rezdiffra (resmetirom) for treatment of adults with noncirrhotic non-alcoholic steatohepatitis...
FDA approves semaglutide for major heart disease prevention among obese Dr. Kamal Kant Kohli10 March 2024 9:15 PM ISTThe US Food and Drug Administration (FDA) has approved semaglutide (Wegovy) for reducing risk of cardiovascular death, heart attack, and stroke in...
FDA Clears First Over-the-Counter Continuous Glucose Monitor Dr. Kamal Kant Kohli8 March 2024 6:00 AM ISTToday, the U.S. Food and Drug Administration cleared for marketing the first over-the-counter (OTC) continuous glucose monitor (CGM). The Dexcom Stelo...
FDA approves new dermal filler for hollows in upper face Dr. Kamal Kant Kohli6 March 2024 6:00 PM ISTThe US Food and Drug Administration (FDA) has approved hyaluronic acid dermal filler, Juvederm Voluma XC for use in upper face for first time. The...
Yogurt consumption can reduce type 2 diabetes risk: US FDA allows qualified health claim Medha Baranwal5 March 2024 6:59 PM ISTUSA: The U.S. Food and Drug Administration (FDA) announced in a letter of enforcement discretion that it will not object to using certain qualified...
FDA approves Exblifep for complicated UTI including pyelonephritis Dr. Kamal Kant Kohli1 March 2024 11:30 PM ISTThe US Food and Drug Administration (FDA) has approved Exblifep (cefepime/enmetazobactam) for treatment of complicated urinary tract infections...
